Brief: Glenmark Pharma U.S. Unit Buys Approved ANDAs From Wockhardt
28/06/2022 04:11
June 28 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS :
* UNIT BUYS APPROVED ANDAS IN UNITED STATES FROM WOCKHARDT
Source text for Eikon: ID:nBSE8h8ZR9
Further company coverage: GLEN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter